retatrutide phase 2 trial type 2 diabetes weight loss 2024 Survodutide vs. for Retatrutide Shows Promising Results in – retatrutide for diabetes type 2 – retatrutide phase 2 trial type

Often theres a wide-range of symptoms that dont seem to add up

Dr Lauren OConnor from George Washington University and colleagues assessed outcomes among 362 people with HIV who took GLP-1 medications for at least six months

Semaglutide, a long-acting GLP-1 agonist, exhibited a sustained weight decrease of approximately 15% of body weight in clinical studies, whereas tirzepatide, a combination GIP/GLP-1 agonist, attained a weight loss of up to 22.5% in the SURMOUNT trials [36,37]

Unfortunately, a study published in JAMA, found that the use of certain diabetes or weight loss medications (i.e., GLP-1 agonists such as Ozempic, Mounjaro, Wegovy, or Rybelsus) may be associated with an increased risk of developing stomach paralysis or gastroparesis

Mindfulness and acceptance-based interventions, such as mindfulness-based cognitive therapy, mindfulness-based stress reduction, and acceptance and commitment therapy, are therapeutic approaches to enhance psychological flexibility, awareness, and non-judgmental acceptance of present-moment experiences, including bodily sensations, thoughts, and feelings [220]